April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
MMP/TIMP Profiles in the Aqueous Humor of Glaucoma Patients: Effect of Antiglaucoma Drugs
A. W. Krysta; M. Zenkel; J. Djordjevic-Jocic; P. Lewczuk; A. G. Junemann; F. E. Kruse; J. Kornhuber; U. Schlotzer-Schrehardt
Author Affiliations & Notes
  • A. W. Krysta
    Department of Ophthalmology,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • M. Zenkel
    Department of Ophthalmology,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • J. Djordjevic-Jocic
    Clinic of Ophthalmology, Clinical Centre Nis, Nis, Serbia
  • P. Lewczuk
    Department of Psychiatry,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • A. G. Junemann
    Department of Ophthalmology,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • F. E. Kruse
    Department of Ophthalmology,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • J. Kornhuber
    Department of Psychiatry,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • U. Schlotzer-Schrehardt
    Department of Ophthalmology,
    University of Erlangen - Nuremberg, Erlangen, Germany
  • Footnotes
    Commercial Relationships  A.W. Krysta, None; M. Zenkel, None; J. Djordjevic-Jocic, None; P. Lewczuk, None; A.G. Junemann, None; F.E. Kruse, None; J. Kornhuber, None; U. Schlotzer-Schrehardt, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6113. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      MMP/TIMP Profiles in the Aqueous Humor of Glaucoma Patients: Effect of Antiglaucoma Drugs
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      A. W. Krysta, M. Zenkel, J. Djordjevic-Jocic, P. Lewczuk, A. G. Junemann, F. E. Kruse, J. Kornhuber, U. Schlotzer-Schrehardt; MMP/TIMP Profiles in the Aqueous Humor of Glaucoma Patients: Effect of Antiglaucoma Drugs. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6113.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : Matrix metalloproteases (MMPs) and their tissue inhibitors (TIMPs) are implicated in the pathophysiology of glaucoma. We investigated the concentrations of MMPs and TIMPs in the aqueous humor of patients with pseudoexfoliation glaucoma (PEXG) and primary open-angle glaucoma (POAG) without and with antiglaucoma medications as well as of control patients with cataract.

Methods: : Fluorokine MultiAnalyte Profiling kits and Luminex technology were used to simultaneously measure MMP-1/-2/-3/-7/-9/-12/-13 and TIMP-1/-2/-3/-4 in aqueous humor samples obtained from patients with cataract, PEXG and POAG without or with antiglaucomatous drug therapy (latanoprost or timolol/dorzolamide) for at least 12 months (n≥10 for each group) during cataract or glaucoma surgery after informed consent. Data were statistically analyzed by the Mann-Whitney test.

Results: : MMP-1/-2/-3/-7/-9 and TIMP-1/-2/-3/-4 were identified in human aqueous humor samples from all groups of patients with highest levels for MMP-2 and TIMP-2, whereas MMP-12 and -13 were below detection limit. Compared with cataract patients, all four TIMPs were significantly increased in aqueous samples from both untreated and treated PEXG and POAG patients, whereas MMP-2 and -7 were increased in untreated PEXG patients only. Compared with untreated glaucoma patients, treatment with latanoprost resulted in a significant increase in aqueous MMP-1 levels of both PEXG and POAG patients as well as a reduction of MMP-7 levels in PEXG patients and a reduction of TIMP-1 and -4 in POAG patients only. Glaucoma medication had no significant effect on aqueous levels of MMP-2/-3/-9 and TIMP-2/-3.

Conclusions: : Increased aqueous concentrations of TIMPs were confirmed to be associated with both PEXG and POAG. Latanoprost therapy significantly influenced aqueous concentrations of MMP-1 and TIMP-1/4 levels and may confer beneficial effects on the abnormal matrix accumulations in both types of glaucoma.

Keywords: enzymes/enzyme inhibitors • aqueous 
© 2010, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept